Aurora Cannabis (ACB) Scheduled to Post Earnings on Tuesday – MarketBeat

Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Aurora Cannabis (NYSE:ACBGet Rating) is scheduled to post its quarterly earnings results after the market closes on Tuesday, September 20th. Analysts expect Aurora Cannabis to post earnings of ($0.12) per share for the quarter. Persons that are interested in participating in the company’s earnings conference call can do so using this link.

Aurora Cannabis Trading Up 3.2 %

Shares of ACB opened at $1.61 on Tuesday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 4.76 and a current ratio of 5.85. Aurora Cannabis has a 52-week low of $1.21 and a 52-week high of $8.69. The firm has a market cap of $365.14 million, a price-to-earnings ratio of -0.35 and a beta of 2.64. The business’s fifty day moving average is $1.51 and its 200-day moving average is $2.32.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on ACB shares. CIBC reduced their target price on Aurora Cannabis from C$6.50 to C$3.75 in a research note on Monday, May 16th. Cantor Fitzgerald raised shares of Aurora Cannabis from a “neutral” rating to an “overweight” rating in a research report on Friday, June 24th. Finally, Stifel Nicolaus upgraded shares of Aurora Cannabis from a “sell” rating to a “hold” rating and set a $2.15 price target on the stock in a research note on Monday, June 6th. Two analysts have rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $4.97.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the stock. Goldman Sachs Group Inc. lifted its stake in Aurora Cannabis by 283.9% during the second quarter. Goldman Sachs Group Inc. now owns 608,452 shares of the company’s stock worth $803,000 after purchasing an additional 449,969 shares during the last quarter. Cubist Systematic Strategies LLC increased its stake in Aurora Cannabis by 95.2% in the 2nd quarter. Cubist Systematic Strategies LLC now owns 243,221 shares of the company’s stock worth $321,000 after purchasing an additional 118,648 shares in the last quarter. Quantbot Technologies LP boosted its position in Aurora Cannabis by 32,475.2% during the 2nd quarter. Quantbot Technologies LP now owns 139,096 shares of the company’s stock worth $183,000 after acquiring an additional 138,669 shares during the period. Renaissance Technologies LLC lifted its holdings in shares of Aurora Cannabis by 267.4% during the 2nd quarter. Renaissance Technologies LLC now owns 3,220,384 shares of the company’s stock valued at $4,251,000 after buying an additional 2,343,884 shares during the last quarter. Finally, LPL Financial LLC raised its stake in shares of Aurora Cannabis by 28.4% in the 2nd quarter. LPL Financial LLC now owns 80,182 shares of the company’s stock valued at $106,000 after acquiring an additional 17,721 shares in the last quarter. 29.53% of the stock is currently owned by hedge funds and other institutional investors.

Aurora Cannabis Company Profile

(Get Rating)
Aurora Cannabis Inc produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients.

Read More

Earnings History for Aurora Cannabis (NYSE:ACB)
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Before you consider Aurora Cannabis, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Aurora Cannabis wasn’t on the list.
While Aurora Cannabis currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Complete the form below to receive the latest headlines and analysts’ recommendations for your stocks with our free daily email newsletter:
ETF portfolio manager, Dave Gilreath offers a perspective on “dividend achievers” and why these deserve a role in your portfolio
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.
Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.
Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.
As Featured By:
MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.
Twitter Facebook StockTwits Financial Juice YouTube
MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot
© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart’s disclaimer.

source

medicalau
medicalau

Buy Weed In Australia

Articles: 148

Leave a Reply

Your email address will not be published.